We speak to Alka Singh about joining Mtech Access’ Systeamtic Review team. We learn about her career to date, her move to the UK and her experiences since joining the team.
Read More
How can the life sciences industry and the NHS work together to deliver real change? An overview of the key themes from our 2023 NHS Transformation Symposium.
On Wednesday 16th August Calum Jones (Senior Consultant – Health Economics, Mtech Access) spoke to Dr George Magrath (CEO, Lexitas) about the use of AI in clinical trials, where and...
Read More
Jodie Worrall recently joined Mtech Access as an Associate Director, leading our Evidence Synthesis and Systematic Review team alongside Shona Lang. In this interview, we learn about her expertise, her travels and what its been like returning to consultancy, at Mtech Access.
Visit our virtual booth We are delighted to announce that we will be exhibiting at The MedTech Forum on 30th May – 1st June in Dublin. The event is MedTech...
Read More
Working with a dedicated market access and health economics and outcomes research (HEOR) consultancy offers significant added value to Pharma and Medical Device companies and can give you the confidence...
Read More
Araadhna Sinha tells us about her research evaluating NICE’s new disease severity modifier. Including the impact it could have had on past Health Technology Assessments.
Edyta Ryczek tells us about her research into the inclusion of Carer Health-Related Quality of Life measures in NICE Appraisals
Elizabeth Thurgar tells us about her ISPOR poster reviewing fast-track appraisals at NICE and the evolution of cost comparison
Olivia Dickinson tells us about her research reviewing oncology submissions to NICE to see how often QoL data is accepted.
